|
⚲
|
| Keyboard |
| Ian Clark | |
|---|---|
| Firm | |
| Address | c/o Olema Pharmaceuticals, Inc 780 Brannan Street San Francisco, CA 94103 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | 021-531835 | Director | 250.0 M of 250.0 M |
||
| Asher Biotherapeutics Inc | 021-510726 | Director | 55.0 M of 55.0 M |
||
| Kyverna Therapeutics Inc | 021-496597 | Director | 152.0 M of 152.0 M |
||
| Olema Pharmaceuticals Inc | 021-492146 | Director | 130.0 M of 130.0 M |
||
| Gyroscope Therapeutics Ltd | 021-395903 | Director | 148.0 M of 148.0 M |
||
| Olema Pharmaceuticals Inc | 021-377769 | Director | 87.4 M of 87.4 M |
||
| X-Vax Technology Inc | 021-322669 | Director | 56.5 M of 58.0 M |
||
| AVROBIO Inc | 021-304752 | Director | 60.5 M of 61.0 M |
||
| Solazyme Inc | 021-259885 | Director | 28.8 M of 28.8 M |
||
| Dichotomy Partners LP | 021-191856 | Executive Officer | 0.3 M | ||